Monday November 9 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Cancer Center of Boston

Below is an extended Cancer Center of Boston news listing. Click here to return to the Cancer Center of Boston main Biocorporate entry.

BioNews Results for Cancer Center of Boston:
Concert a benefit for cancer patients Portsmouth Herald: Nov 1 2009 7:54AM Matching: cancer center boston
Carmel Pharma Introduces PhaSeal, Secondary Set (C60) Therapeutics Daily: Nov 1 2009 1:26PM Matching: cancer center boston
Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Journal of Clinical Oncology: Oct 31 2009 5:47PM Matching: cancer center boston
Randomized Phase II Study of Gemcitabine Administered at a Fixed Dose Rate or in Combination With Cisplatin, D Journal of Clinical Oncology: Oct 31 2009 5:51PM Matching: cancer center boston
American Society of Clinical Oncology 2009 Clinical Evidence Review on Radiofrequency Ablation of Hepatic Meta Journal of Clinical Oncology: Oct 31 2009 5:50PM Matching: cancer center boston
Cediranib, an Oral Inhibitor of Vascular Endothelial Growth Factor Receptor Kinases, Is an Active Drug in Recu Journal of Clinical Oncology: Oct 31 2009 5:49PM Matching: cancer center boston
Local Excision Alone Without Irradiation for Ductal Carcinoma In Situ of the Breast: A Trial of the Eastern Co Journal of Clinical Oncology: Oct 31 2009 5:48PM Matching: cancer center boston
Prospective Study of Prostate Tumor Angiogenesis and Cancer-Specific Mortality in the Health Professionals Fol Journal of Clinical Oncology: Oct 31 2009 5:51PM Matching: cancer center boston
Histone Deacetylase Inhibitors in Cancer Therapy [Review Articles] Journal of Clinical Oncology: Oct 31 2009 5:48PM Matching: cancer center boston
Clinical Dilemma of Ductal Carcinoma in Situ [Editorials] Journal of Clinical Oncology: Oct 31 2009 5:49PM Matching: cancer center boston
Schering-Plough receives FDA complete response letter regarding PEGINTRON for malignant melanoma News-Medical.Net: Oct 31 2009 7:12AM Matching: cancer center boston
Phase II Study of Cisplatin Plus Etoposide and Bevacizumab for Previously Untreated, Extensive-Stage Small-Cel Journal of Clinical Oncology: Oct 31 2009 5:52PM Matching: cancer center boston
VMP (Bortezomib, Melphalan, and Prednisone) Is Active and Well Tolerated in Newly Diagnosed Patients With Mult Journal of Clinical Oncology: Oct 31 2009 5:51PM Matching: cancer center boston
Researchers use BEZ235 drug to eliminate NSCL cancer News-Medical.Net: Oct 30 2009 6:40AM Matching: cancer center boston
Theresa C. McLoud M.D., Travels to Argentina through International Education Program RSNA Link: Oct 30 2009 12:53AM Matching: cancer center boston

«Cancer Center of Boston

This page contained an extended Cancer Center of Boston news listing. Click here to return to the Cancer Center of Boston main Biocorporate entry.

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.